Birgit Girshick - 19 Aug 2026 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Reporting relationship
Chief Executive Officer, Director
Issuer ticker
CRL
Reported as of
19 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Aug 2026, 16:37:16 UTC
Prior SEC filing
13 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Birgit Girshick

Key filing fact

Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 20 Aug 2026.

Key facts

  • This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2026, 16:37.

Change

  • Previous filing in this sequence was filed on 13 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001732091 Primary reporting owner

Girshick Birgit

Relationship
Chief Executive Officer, Director
Address
C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON
Signature
/s/ Birgit Girshick
Signature date
19 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Gift

Transaction value
Shares
-528
Change %
-1.5%
Price
$0.000000*
Shares after
35,485
Date
19 Aug 2026
Ownership
Direct
CRL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
43,803
Date
19 Aug 2026
Ownership
Revocable Trust
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .